Financhill
Back

scPharmaceuticals Quote, Financials, Valuation and Earnings

scPharmaceuticals Price Quote

$4.49

scPharmaceuticals Key Stats

Sell
35
scPharmaceuticals (SCPH) is a Sell

Day range:
$4.32 - $4.58
52-week range:
$4.25 - $12.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.72
P/B ratio:
4.35%

Volume:
119.5K
Avg. volume:
207.5K
1-year change:
-52.74%
Market cap:
$161.9M
Revenue:
$13.6M
EPS:
$-1.42

How Much Does scPharmaceuticals Make?

Is scPharmaceuticals Growing As A Company?

Data Unavailable

scPharmaceuticals Stock Price Performance

  • Did scPharmaceuticals Stock Go Up Last Month?
    scPharmaceuticals share price went down by -8.55% last month
  • Did SCPH's Share Price Rise Over The Last Year?
    SCPH share price fell by -52.74% over the past 1 year

What Is scPharmaceuticals 52-Week High & Low?

scPharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy scPharmaceuticals?

  • How Much Debt Does scPharmaceuticals Have?
    Total long term debt quarterly is $38.8M
  • How Much Cash Does scPharmaceuticals Have?
    Cash and short term investments quarterly total is $76M
  • What Is scPharmaceuticals’s Book Value Per Share?
    Book value per share is 1.03

Is scPharmaceuticals Cash Flow Positive?

  • What Is SCPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.2M
  • What Is scPharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.9M
  • What Is scPharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $20M

scPharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SCPH return on invested capital is -58.05%
  • What Is scPharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -49.59%
  • What Is SCPH Return On Equity?
    ROE is a measure of profitability and is -91.95%

scPharmaceuticals Earnings Date & Stock Price

scPharmaceuticals Competitors

  • Who Are scPharmaceuticals's Competitors?
    Below is a list of companies who compete with scPharmaceuticals or are related in some way:
    • Anika Therapeutics Inc (ANIK)
    • electroCore Inc (ECOR)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Spero Therapeutics Inc (SPRO)

scPharmaceuticals Dividend Yield

Data Unavailable

scPharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.46%
Revenue: 0% 5.63%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.50
Upside from Last Price: 334.3%

Major Shareholders

  • How many SCPH shares are owned by institutional investors?
    33.5M SCPH shares are owned by institutional investors
  • How many SCPH shares are owned by insiders?
    393.4K SCPH shares are owned by insiders